Cargando…
C16 Peptide Promotes Vascular Growth and Reduces Inflammation in a Neuromyelitis Optica Model
The goal of this study was to elucidate the mechanism of action of C16, a laminin-1 peptide that competes with αvβ3 for integrin binding, in treating neuromyelitis optica (NMO). A NMO rat model was established and specific inhibitors were used to investigate the effect of Tie2 kinase, integrin, and...
Autores principales: | Chen, Haohao, Fu, Xiaoxiao, Jiang, Jinzhan, Han, Shu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902286/ https://www.ncbi.nlm.nih.gov/pubmed/31849648 http://dx.doi.org/10.3389/fphar.2019.01373 |
Ejemplares similares
-
Combination Treatment of C16 Peptide and Angiopoietin-1 Alleviates Neuromyelitis Optica in an Experimental Model
por: Zhang, Yuanyuan, et al.
Publicado: (2018) -
Neuromyelitis Optica
por: Misra, M. C., et al.
Publicado: (1953) -
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014) -
The history of neuromyelitis optica
por: Jarius, Sven, et al.
Publicado: (2013) -
Neuromyelitis optica and neuroregeneration
Publicado: (2012)